Craneware plc

("Craneware" or the "Company")

Grant of Long Term Incentive Plan Awards

19 November 2021 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 18 November 2021, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to two Directors of the Company as follows:  

The awards will ordinarily vest after three years subject to:

(i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and

(ii) the Director's continued employment.

The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2022, one third based on performance over the three years ending 30 June 2023 and the final third based on performance over the three years to 30 June 2024 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse.

If and to the extent that these LTIP awards vest, the resulting (net of tax) Shares will be subject to a two year holding period.

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. 

PDMR notification: Keith Neilson

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Keith Neilson

2.   Reason for the notification

a) Position / status                                            CEO

b) Initial notification / Amendment                       Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code                                         ISIN GB00B2425G68

c) Nature of the transaction                                Grant of conditional share award under the Craneware plc

                                                                                    Long Term Incentive Plan (2016)

d) Price(s) and volume(s)                                   Volume(s) granted 24,896, Price(s) £0

e) Aggregated information:

                                    i. Aggregated volume                Aggregate volume granted 24,896 

                                    ii. Price                                     Price(s) £0

f) Date of the transaction                                   2021-11-18

g) Place of the transaction                                 Outside a trading venue

PDMR notification: Craig Preston

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Craig Preston

2.   Reason for the notification

a) Position / status                                            CFO

b) Initial notification / Amendment                       Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code                                         ISIN GB00B2425G68

c) Nature of the transaction                                Grant of conditional share award under the Craneware plc

                                                                                    Long Term Incentive Plan (2016)

d) Price(s) and volume(s)                                   Volume(s) granted 18,505, Price(s) £0

e) Aggregated information:

                                    i. Aggregated volume                Aggregate volume granted 18,505

                                    ii. Price                                     Price(s) £0

f) Date of the transaction                                   2021-11-18

g) Place of the transaction                                 Outside a trading venue

For further information, please contact:

About Craneware

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2000 U.S hospitals and health systems and almost 10,000 clinics and retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at craneware.com